SCHEMBL3830877

SCHEMBL3830877

CC(=O)OS(=N)(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
BCAT1 P54687 1/20 0.47
ALDH1A1 P00352 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 2/20 0.41
GAA P10253 1/20 0.40
HTR6 P50406 1/20 0.39
HSD11B1 P28845 3/20 0.39
PSIP1 O75475 1/20 0.39
HTT P42858 1/20 0.39
KAT6A Q92794 1/20 0.38
POLB P06746 1/20 0.38
LMNA P02545 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3830874 1.00 BCAT1 (0.47) BCAT1ALDH1A1KMT2ASMN1; SMN2TSHR
SCHEMBL722599 0.79 BCAT1 (0.46) BCAT1ALDH1A1KMT2ASMN1; SMN2TSHR
SCHEMBL31215190 0.79 BCAT1 (0.46) BCAT1ALDH1A1KMT2ASMN1; SMN2TSHR
SCHEMBL6261806 0.78 BCAT1 (0.44) BCAT1ALDH1A1KMT2ASMN1; SMN2TSHR
Water SCHEMBL27820714 0.78 BCAT1 (0.44) BCAT1ALDH1A1KMT2ASMN1; SMN2TSHR
Guanidine SCHEMBL5918484 0.77 BCAT1 (0.41) BCAT1ALDH1A1KMT2ASMN1; SMN2TSHR
SCHEMBL106041 0.77 BCAT1 (0.42) BCAT1ALDH1A1KMT2ASMN1; SMN2TSHR
SCHEMBL28496246 0.75 BCAT1 (0.41) BCAT1ALDH1A1KMT2ASMN1; SMN2TSHR
Tetramethylammonium Ion SCHEMBL5422588 0.74 BCAT1 (0.42) BCAT1ALDH1A1KMT2ASMN1; SMN2TSHR
SCHEMBL6365074 0.73 HTR6 (0.52) ALDH1A1KMT2ASMN1; SMN2GAAHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099757-A2 SULFOXIMINES AS KINASE INHIBITORS Allergan, Inc. (US) 2009-09-16 EP disclosed
WO-2008061236-A2 SULFOXIMINES AS KINASE INHIBITORS ALLERGAN, INC. (US) 2008-05-22 WO disclosed